期刊文献+

甲状腺癌中CD_(44)V6和基质金属蛋白酶-2的表达 被引量:1

Expression of CD_(44)V6 and MMP-2 in human thyroid carcinoma
在线阅读 下载PDF
导出
摘要 目的研究黏附分子CD_(44)V6、基质金属蛋白酶-2(MMP-2)在甲状腺癌中的表达、相互关系及其与甲状腺癌侵袭转移的相关性。方法应用S-P免疫组化染色法检测82例甲状腺乳头状癌(PTC)中CD_(44)V6和MMP-2表达。结果82例甲状腺乳头状癌(PTC)中CD_(44)V6和MMP-2阳性表达率为67.1%和68.3%,均高于甲状腺腺瘤周围正常甲状腺组织,P<0.01。CD_(44)V6和MMP-2阳性表达与淋巴结转移呈正相关,P<0.05,且随侵袭程度增加而升高。结论CD44V6、MMP-2在促进甲状腺癌的浸润与转移中呈协同效应,CD_(44)V6和MMP-2表达的综合检测对甲状腺癌转移趋势和预后评估具有重要的参考价值,可能是甲状腺癌侵袭转移、预后判断的分子标志。 [Objective] To investigate the correlation between the expression of CD44V6,MMP-2 and invasion, metastasis in thyriod carcinoma. [Methods] The SP immunohistochemical method was employed to detect the expression of CD44V6 and MMP-2 in 82 cases thyroid papillary carcinomas (PTC). [Results] The positive rate of CD44V6 and MMP-2 was 67.1% and 68.3% respectively in PTCs, both of which was significantly higher than that in the tissues adjacent to thyroid adenomas (P 〈0.01). Overexpressions of CD44V6 and MMP-2 in PTCs was related to lymph node metastasis(P 〈0.05). The positive expression of CD44V6 and MMP-2 had a rising tendency with the advancing invasion. [Conclusion] The expression of CD44V6 and MMP-2 is of common effects in invasion and metastasis. To detect the expression of CD44V6 and MMP-2 is of great value, they are related to the diagnoses, differentiation and metastasis of thyroid carcinoma and may be molecular markers to value the invasion and metastasis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第22期3421-3423,共3页 China Journal of Modern Medicine
基金 湖南省卫生厅科研基金资助(编号:B2005-122)
关键词 甲状腺癌 CD44V6 基质金属蛋白酶-2 thyroid carcinoma CD44V6 matrix metaUoproteinase-2 (MMP-2)
  • 相关文献

参考文献5

二级参考文献24

  • 1Thapar K, Kovas K, Scheithauer BW, et al . Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using MIB-1 antibody. Neurosurgery, 1996,38(1) :99~107.
  • 2Pegolo G, Faizen P, Vize E, et al. Pituitary adenomas, correlation of the cytological appearance with biological behavior.Acta Cytol, 1995, 39(5): 887~92.
  • 3Scheithauer BW, Kovacs KT, Laws ER Jr, et al. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg ,1986,65(6) :733~44.
  • 4Friedrichs K, Gluba S, Eidtmann H, et al. Overexpression of p53 and prognosis in breast cancer. Cancer, 1993, 72 (12):3641~7.
  • 5Selman WR, Laws ER Jr, Scheithauer BW, et al. The occurrence of dual invasive in pituitary adenomas. J Neurosurg,1986, 64(3):402~27.
  • 6Meij B, Lopes M, Ellegala D, etal. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg,2002, 96(2) :195~208.
  • 7Ray JM, Stetler-Stevenson WG. The role matrix metalloproteases and their inhibitors in tumor invasion , metastasis and angiogenesis. Eur Respir J, 1994, 7(11) :2062~72.
  • 8Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol, 1999 , 189(3):300~8.
  • 9Fletcher CDM. Diagnostic histopathology of tumors . London: Churchill Ltd, 1995:588~95.
  • 10Turner HE, Nagy Z, Esiri MM, etal. Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab, 2000, 85(8):2931~5.

共引文献31

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部